Forgot your password?

An unicorn was born: the Belarusian origin company PandaDoc received an estimate of $1B

Wednesday, September 22, 2021

It became known that the startup of Belarusian entrepreneur Mikita Mikado PandaDoc closed round C with an estimate exceeding $1B.

Startup Jedi

We talk to startups and investors, you get the value.

A few hours ago it became known that the startup of Belarusian entrepreneur Mikita Mikado PandaDoc closed round C with an estimate exceeding $1B. This gives PandaDoc the status of a “unicorn” and elevates him to the technological leaders of the market today.

OMERS Growth Equity and G Squared led the round, as well as Altos Ventures, Rembrandt Venture Partners, One Peak Partners and M12.

Currently PandaDoc's customers are in 130 countries, and its user base has grown 80% over the past year and its revenue jumped 63%.

The management team is one of the best we've ever seen and we look forward to supporting their creative and effective approach to this fast-growing area”, says Larry Ashebrook, Managing Partner at G Squared, about his impressions of the project. 

In turn, Mark Shulgan, Managing Partner and Head of OMERS Growth Equity, called PandaDoc “an innovative company that is shaping the future of documents with its robust, versatile automation platform”.

In his interview for TechCrunch, Mikida Mikado noted that the funds raised will help the company both expand its functionality and deepen the existing ones. The project also plans to enter the world market and international growth.

The Startup Jedi team congratulates PandaDoc on the success! Further more!

22 Sep 2021

 

Stay tuned and don’t forget to follow us:

Facebook: facebook.com/StartupJedi/

Telegram: t.me/Startup_Jedi

Twitter: twitter.com/startup_jedi

Comments

More From Startup Jedi

The closer the end of the year, the more news. Gathered a new harvest of the best!
First autumn news run this year: check out new rounds, deals, and tech news.
Genius or insane? Taking about the failure of Elizabeth Holmes and the Theranos company.